Skip to content

Clinical Efficacy Assessment of Integrated Chinese-Western Medicine for Myopia Control

Clinical Efficacy Assessment of Integrated Chinese-Western Medicine for Myopia Control

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115636
Enrollment
Unknown
Registered
2025-12-29
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Integrated Chinese-Western Medicine Group (Peripheral Defocus Spectacles + Standardized Acupuncture Protocol):None
Western Medicine Group (Peripheral Defocus Spectacles):None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.Spherical equivalent refraction between -0.50D and -6.00D; 2.Astigmatism = 0.8; 4.Normal binocular vision (including stereopsis), without strabismus, amblyopia, or nystagmus; 5.Intraocular pressure within normal range (10mmHg to 21mmHg);

Exclusion criteria

Exclusion criteria: 1.Other eye diseases; 2.Previous history of orthokeratology lens use or refractive surgery; 3.Participants with poor compliance or unqualified image quality; 4.Contraindications to acupuncture (e.g., bleeding tendency, etc.);

Design outcomes

Primary

MeasureTime frame
Axial length;

Secondary

MeasureTime frame
Best corrected visual acuity;Retinal / Choroidal vascularity and thickness;Refractive error;complication rate;

Countries

China

Contacts

Public ContactZhangliang Li

Eye Hospital, Wenzhou Medical University

lizhangliang0328@126.com+86 571 8673 8019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026